Barbara Meissner
Barbara Meissner
BC Cancer, Vancouver
Verified email at
Cited by
Cited by
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
RD Morin, M Mendez-Lago, AJ Mungall, R Goya, KL Mungall, RD Corbett, ...
Nature 476 (7360), 298-303, 2011
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
DB Yap, J Chu, T Berg, M Schapira, SWG Cheng, A Moradian, RD Morin, ...
Blood 117 (8), 2451-2459, 2011
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ...
Nature 471 (7338), 377-381, 2011
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
RD Morin, K Mungall, E Pleasance, AJ Mungall, R Goya, RD Huff, ...
Blood 122 (7), 1256-1265, 2013
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
R Kridel, B Meissner, S Rogic, M Boyle, A Telenius, B Woolcock, ...
Blood, The Journal of the American Society of Hematology 119 (9), 1963-1971, 2012
Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma
R Rahal, M Frick, R Romero, JM Korn, R Kridel, FC Chan, B Meissner, ...
Nature medicine 20 (1), 87-92, 2014
Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies
DW Scott, A Mottok, D Ennishi, GW Wright, P Farinha, S Ben-Neriah, ...
Journal of clinical oncology 33 (26), 2848, 2015
Deletion of the intestinal peptide transporter affects insulin and TOR signaling in Caenorhabditis elegans
B Meissner, M Boll, H Daniel, R Baumeister
Journal of Biological Chemistry 279 (35), 36739-36745, 2004
Gene expression–based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma
DW Scott, FC Chan, F Hong, S Rogic, KL Tan, B Meissner, S Ben-Neriah, ...
Journal of Clinical Oncology 31 (6), 692, 2013
The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma
B Meissner, R Kridel, RS Lim, S Rogic, K Tse, DW Scott, R Moore, ...
Blood 121 (16), 3161-3164, 2013
Histological transformation and progression in follicular lymphoma: a clonal evolution study
R Kridel, FC Chan, A Mottok, M Boyle, P Farinha, K Tan, B Meissner, ...
PLoS medicine 13 (12), e1002197, 2016
An integrated strategy to study muscle development and myofilament structure in Caenorhabditis elegans
B Meissner, A Warner, K Wong, N Dube, A Lorch, SJ McKay, J Khattra, ...
PLoS genetics 5 (6), e1000537, 2009
Cell of origin of transformed follicular lymphoma
R Kridel, A Mottok, P Farinha, S Ben-Neriah, D Ennishi, Y Zheng, ...
Blood, The Journal of the American Society of Hematology 126 (18), 2118-2127, 2015
Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact
D Ennishi, A Mottok, S Ben-Neriah, HP Shulha, P Farinha, FC Chan, ...
Blood 129 (20), 2760-2770, 2017
PEPT1‐mediated uptake of dipeptides enhances the intestinal absorption of amino acids via transport system b0,+
U Wenzel, B Meissner, F Döring, H Daniel
Journal of Cellular Physiology 186 (2), 251-259, 2001
Determining the sub-cellular localization of proteins within Caenorhabditis elegans body wall muscle
B Meissner, T Rogalski, R Viveiros, A Warner, L Plastino, A Lorch, ...
PloS one 6 (5), e19937, 2011
Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma
SE Arthur, A Jiang, BM Grande, M Alcaide, R Cojocaru, CK Rushton, ...
Nature communications 9 (1), 1-14, 2018
Assessment of capture and amplicon-based approaches for the development of a targeted next-generation sequencing pipeline to personalize lymphoma management
SS Hung, B Meissner, EA Chavez, S Ben-Neriah, D Ennishi, MR Jones, ...
The Journal of Molecular Diagnostics 20 (2), 203-214, 2018
High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology
LC Chong, S Ben-Neriah, GW Slack, C Freeman, D Ennishi, A Mottok, ...
Blood advances 2 (20), 2755-2765, 2018
A time-and-motion approach to micro-costing of high-throughput genomic assays
S Costa, DA Regier, B Meissner, I Cromwell, S Ben-Neriah, E Chavez, ...
Current Oncology 23 (5), 304, 2016
The system can't perform the operation now. Try again later.
Articles 1–20